Saluda Medical, Inc. (ASX:SLD)
Australia · Delayed Price · Currency is AUD 0.6000
-0.0200 (-3.23%)
At close: Aug 12, 2026
Saluda Medical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Saluda Medical stock has a consensus rating of "Strong Buy" and an average price target of $2.17. The average 1-year stock price forecast is 261.67% higher than the current stock price, while the lowest is $1.59 (+165.00%) and the highest is $2.95 (+391.67%).
Price Target: $2.17 (+261.67%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Saluda Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 3 |
Financial Forecast
Revenue This Year
88.33M
from 70.36M
Increased by 25.55%
Revenue Next Year
124.28M
from 88.33M
Increased by 40.70%
EPS This Year
-0.48
EPS Next Year
-0.37
from -0.48
EPS and Forward PE are based on non-GAAP adjusted numbers.